Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial

Nicola Potere; Marcello Di Nisio; Ettore Porreca; Tzu Fei Wang; Vicky Tagalakis; Sudeep Shivakumar; Aurélien Delluc; Ranjeeta Mallick; Phil S. Wells; Marc Carrier

doi:10.1016/j.thromres.2023.04.015

Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial

Nicola Potere, Marcello Di Nisio, Ettore Porreca, Tzu Fei Wang, Vicky Tagalakis, Sudeep Shivakumar, Aurélien Delluc, Ranjeeta Mallick, Phil S. Wells, Marc Carrier

Research output: Contribution to journal › Letter › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	82-85
Number of pages	4
Journal	Thrombosis Research
Volume	226
DOIs	https://doi.org/10.1016/j.thromres.2023.04.015
Publication status	Published - Jun 2023
Externally published	Yes

ASJC Scopus Subject Areas

Hematology

Keywords

Bleeding
Neoplasms
Obesity
Pulmonary embolism
Venous thromboembolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.thromres.2023.04.015

Cite this

Potere, N., Di Nisio, M., Porreca, E., Wang, T. F., Tagalakis, V., Shivakumar, S., Delluc, A., Mallick, R., Wells, P. S., & Carrier, M. (2023). Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial. Thrombosis Research, 226, 82-85. https://doi.org/10.1016/j.thromres.2023.04.015

@article{025716ecf10645d58d8e3a0cf93111c0,

title = "Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial",

keywords = "Bleeding, Neoplasms, Obesity, Pulmonary embolism, Venous thromboembolism",

author = "Nicola Potere and {Di Nisio}, Marcello and Ettore Porreca and Wang, {Tzu Fei} and Vicky Tagalakis and Sudeep Shivakumar and Aur{\'e}lien Delluc and Ranjeeta Mallick and Wells, {Phil S.} and Marc Carrier",

note = "Publisher Copyright: {\textcopyright} 2023 Elsevier Ltd",

year = "2023",

month = jun,

doi = "10.1016/j.thromres.2023.04.015",

language = "English",

volume = "226",

pages = "82--85",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity

T2 - Insights from the AVERT trial

AU - Potere, Nicola

AU - Di Nisio, Marcello

AU - Porreca, Ettore

AU - Wang, Tzu Fei

AU - Tagalakis, Vicky

AU - Shivakumar, Sudeep

AU - Delluc, Aurélien

AU - Mallick, Ranjeeta

AU - Wells, Phil S.

AU - Carrier, Marc

PY - 2023/6

Y1 - 2023/6

KW - Bleeding

KW - Neoplasms

KW - Obesity

KW - Pulmonary embolism

KW - Venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=85153795561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85153795561&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2023.04.015

DO - 10.1016/j.thromres.2023.04.015

M3 - Letter

AN - SCOPUS:85153795561

SN - 0049-3848

VL - 226

SP - 82

EP - 85

JO - Thrombosis Research

JF - Thrombosis Research

ER -

Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this